AURAAura Biosciences, Inc.
- Market cap
- $653.34M
- as of 2026-10-23
- Latest close
- $6.30
- as of 2026-10-23
- Sector
- Healthcare
- as of 2026-10-24
- Industry
- Biotechnology
- as of 2026-10-24
Cluster
No cluster in the last 90 days under the default rule (14d · ≥2 insiders · all roles).
Form 4 historysince 2023-10-05
| Insider | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| Person JulieChief People Officer | Sep 1 | Sep 1 | A | 107,611 | $0.00 | $0 | 107,611 | No | Form 4 |
| Person JulieChief People Officer | Sep 1 | Sep 1 | A · derivative | 212,389 | $7.43 | $1,578,050 | 212,389 | No | Form 4 |
| Hopkins Janet JillChief Medical Officer | Sep 1 | Sep 1 | A | 58,850 | $0.00 | $0 | 380,190 | No | Form 4 |
| Hopkins Janet JillChief Medical Officer | Sep 1 | Sep 1 | A · derivative | 116,150 | $7.43 | $862,995 | 116,150 | No | Form 4 |
| Elazzouzi AmySVP, Finance & PAO | Sep 1 | Sep 1 | A | 23,540 | $0.00 | $0 | 143,600 | No | Form 4 |
| Elazzouzi AmySVP, Finance & PAO | Sep 1 | Sep 1 | A · derivative | 46,460 | $7.43 | $345,198 | 46,460 | No | Form 4 |
| Abu-Absi SusanChief Operating Officer | Sep 1 | Sep 1 | A | 134,513 | $0.00 | $0 | 134,513 | No | Form 4 |
| Abu-Absi SusanChief Operating Officer | Sep 1 | Sep 1 | A · derivative | 265,487 | $7.43 | $1,972,568 | 265,487 | No | Form 4 |
| Kratz EricaChief Reg. & Quality Officer | Sep 1 | Sep 1 | A | 100,885 | $0.00 | $0 | 100,885 | No | Form 4 |
| Kratz EricaChief Reg. & Quality Officer | Sep 1 | Sep 1 | A · derivative | 199,115 | $7.43 | $1,479,424 | 199,115 | No | Form 4 |
| Bender Jeremy | Jul 7 | Jul 8 | A | 30,000 | $0.00 | $0 | 30,000 | No | Form 4 |
| Bender Jeremy | Jul 7 | Jul 8 | A · derivative | 60,000 | $7.03 | $421,800 | 60,000 | No | Form 4 |
| Kilroy ConorSee Remarks | Jul 1 | Jul 1 | A | 14,858 | $0.00 | $0 | 232,693 | No | Form 4 |
| Gibney Anthony SSee Remarks | Jun 16 | Jun 16 | S | 12,824 | $6.42 | Sale −$82,330 | 265,354 | No | Form 4 |
| Mattessich Antony C. | Jun 11 | Jun 15 | A | 15,000 | $0.00 | $0 | 38,500 | No | Form 4 |
| Mattessich Antony C. | Jun 11 | Jun 15 | A · derivative | 30,000 | $6.21 | $186,300 | 30,000 | No | Form 4 |
| Johnson David Michael | Jun 11 | Jun 15 | A | 15,000 | $0.00 | $0 | 194,167 | No | Form 4 |
| Johnson David Michael | Jun 11 | Jun 15 | A · derivative | 30,000 | $6.21 | $186,300 | 30,000 | No | Form 4 |
| Srivastava Sapna | Jun 11 | Jun 15 | A | 15,000 | $0.00 | $0 | 38,500 | No | Form 4 |
| Srivastava Sapna | Jun 11 | Jun 15 | A · derivative | 30,000 | $6.21 | $186,300 | 30,000 | No | Form 4 |
| Bitetti Teresa Marie | Jun 11 | Jun 15 | A | 15,000 | $0.00 | $0 | 36,000 | No | Form 4 |
| Bitetti Teresa Marie | Jun 11 | Jun 15 | A · derivative | 30,000 | $6.21 | $186,300 | 30,000 | No | Form 4 |
| Holles Natalie C.See Remarks | May 19 | May 19 | A | 600,118 | $0.00 | $0 | 600,118 | No | Form 4 |
| Holles Natalie C.See Remarks | May 19 | May 19 | A | 553,844 | $0.00 | $0 | 1,153,962 | No | Form 4 |
| Holles Natalie C.See Remarks | May 19 | May 19 | A · derivative | 2,169,103 | $7.39 | $16,029,671 | 2,169,103 | No | Form 4 |
| Matrix Capital Management Company, LP | May 7 | May 11 | S | 6,922,870 | $5.64 | Sale −$39,044,987 | not reported | No | Form 4 |
| Kilroy ConorSee Remarks | Apr 16 | Apr 16 | S | 11,738 | $7.02 | Sale −$82,401 | 217,835 | No | Form 4 |
| Elazzouzi AmySenior Vice President, Finance | Mar 2 | Mar 3 | A | 44,528 | $0.00 | $0 | 120,060 | No | Form 4 |
| Elazzouzi AmySenior Vice President, Finance | Mar 2 | Mar 3 | A · derivative | 80,472 | $6.14 | $494,098 | 80,472 | No | Form 4 |
| Hopkins Janet JillChief Medical Officer | Mar 2 | Mar 3 | A | 89,056 | $0.00 | $0 | 321,340 | No | Form 4 |
| Hopkins Janet JillChief Medical Officer | Mar 2 | Mar 3 | A · derivative | 160,944 | $6.14 | $988,196 | 160,944 | No | Form 4 |
| Plavsic MarkChief Technology Officer | Mar 2 | Mar 3 | A | 62,339 | $0.00 | $0 | 243,736 | No | Form 4 |
| Plavsic MarkChief Technology Officer | Mar 2 | Mar 3 | A · derivative | 112,661 | $6.14 | $691,739 | 112,661 | No | Form 4 |
| de los Pinos ElisabetSee Remarks | Mar 2 | Mar 3 | A | 166,000 | $0.00 | $0 | 575,815 | No | Form 4 |
| de los Pinos ElisabetSee Remarks | Mar 2 | Mar 3 | A · derivative | 249,000 | $6.14 | $1,528,860 | 249,000 | No | Form 4 |
| Gibney Anthony SSee Remarks | Mar 2 | Mar 3 | A | 71,245 | $0.00 | $0 | 278,178 | No | Form 4 |
| Gibney Anthony SSee Remarks | Mar 2 | Mar 3 | A · derivative | 128,755 | $6.14 | $790,556 | 128,755 | No | Form 4 |
| Kilroy ConorSee Remarks | Mar 2 | Mar 3 | A | 62,339 | $0.00 | $0 | 229,573 | No | Form 4 |
| Kilroy ConorSee Remarks | Mar 2 | Mar 3 | A · derivative | 112,661 | $6.14 | $691,739 | 112,661 | No | Form 4 |
| de los Pinos ElisabetSee Remarks | Feb 17 | Feb 17 | S | 47,648 | $5.06 | Sale −$241,099 | 409,815 | No | Form 4 |
| Elazzouzi AmySenior Vice President, Finance | Feb 17 | Feb 17 | S | 8,549 | $5.06 | Sale −$43,258 | 75,532 | No | Form 4 |
| Hopkins Janet JillChief Medical Officer | Feb 17 | Feb 17 | S | 20,401 | $5.06 | Sale −$103,229 | 232,284 | No | Form 4 |
| Plavsic MarkChief Technology Officer | Feb 17 | Feb 17 | S | 15,890 | $5.05 | Sale −$80,245 | 181,397 | No | Form 4 |
| Kilroy ConorSee Remarks | Feb 17 | Feb 17 | S | 12,079 | $5.05 | Sale −$60,999 | 167,234 | No | Form 4 |
| de los Pinos ElisabetSee Remarks | Jan 20 | Jan 20 | S | 16,928 | $4.86 | Sale −$82,270 | 457,463 | No | Form 4 |
| Elazzouzi AmySenior Vice President, Finance | Jan 20 | Jan 20 | S | 1,581 | $4.86 | Sale −$7,684 | 84,081 | No | Form 4 |
| Hopkins Janet JillChief Medical Officer | Nov 17, 2025 | Nov 17, 2025 | S | 17,109 | $5.42 | Sale −$92,731 | 252,685 | No | Form 4 |
| de los Pinos ElisabetSee Remarks | Oct 29, 2025 | Oct 29, 2025 | S | 9,049 | $6.35 | Sale −$57,461 | 474,391 | No | Form 4 |
| Elazzouzi AmySenior Vice President, Finance | Oct 29, 2025 | Oct 29, 2025 | S | 896 | $6.35 | Sale −$5,690 | 85,662 | No | Form 4 |
| Plavsic MarkChief Technology Officer | Oct 16, 2025 | Oct 16, 2025 | S | 12,169 | $6.35 | Sale −$77,273 | 197,287 | No | Form 4 |
| Elazzouzi AmySenior Vice President, Finance | Aug 18, 2025 | Aug 18, 2025 | M | 2,554 | $5.07 | $12,949 | 83,935 | No | Form 4 |
| Elazzouzi AmySenior Vice President, Finance | Aug 18, 2025 | Aug 18, 2025 | M | 1,094 | $5.48 | $5,995 | 85,029 | No | Form 4 |
| Elazzouzi AmySenior Vice President, Finance | Aug 18, 2025 | Aug 18, 2025 | M | 547 | $5.48 | $2,998 | 85,576 | No | Form 4 |
| Elazzouzi AmySenior Vice President, Finance | Aug 18, 2025 | Aug 18, 2025 | M | 547 | $5.21 | $2,850 | 86,123 | No | Form 4 |
| Elazzouzi AmySenior Vice President, Finance | Aug 18, 2025 | Aug 18, 2025 | M | 4,744 | $2.74 | $12,999 | 90,867 | No | Form 4 |
| Elazzouzi AmySenior Vice President, Finance | Aug 18, 2025 | Aug 18, 2025 | M | 1,094 | $3.16 | $3,457 | 91,961 | No | Form 4 |
| Elazzouzi AmySenior Vice President, Finance | Aug 18, 2025 | Aug 18, 2025 | M | 2,319 | $4.25 | $9,856 | 94,280 | No | Form 4 |
| Elazzouzi AmySenior Vice President, Finance | Aug 18, 2025 | Aug 18, 2025 | S | 7,722 | $6.70 | Sale −$51,737 | 86,558 | No | Form 4 |
| Elazzouzi AmySenior Vice President, Finance | Aug 18, 2025 | Aug 18, 2025 | M · derivative | 2,554 | $5.07 | $12,949 | not reported | No | Form 4 |
| Elazzouzi AmySenior Vice President, Finance | Aug 18, 2025 | Aug 18, 2025 | M · derivative | 1,094 | $5.48 | $5,995 | not reported | No | Form 4 |
| Elazzouzi AmySenior Vice President, Finance | Aug 18, 2025 | Aug 18, 2025 | M · derivative | 547 | $5.48 | $2,998 | not reported | No | Form 4 |
| Elazzouzi AmySenior Vice President, Finance | Aug 18, 2025 | Aug 18, 2025 | M · derivative | 547 | $5.21 | $2,850 | not reported | No | Form 4 |
| Elazzouzi AmySenior Vice President, Finance | Aug 18, 2025 | Aug 18, 2025 | M · derivative | 4,744 | $2.74 | $12,999 | not reported | No | Form 4 |
| Elazzouzi AmySenior Vice President, Finance | Aug 18, 2025 | Aug 18, 2025 | M · derivative | 1,094 | $3.16 | $3,457 | not reported | No | Form 4 |
| Elazzouzi AmySenior Vice President, Finance | Aug 18, 2025 | Aug 18, 2025 | M · derivative | 2,319 | $4.25 | $9,856 | not reported | No | Form 4 |
| Mattessich Antony C. | Jun 17, 2025 | Jun 18, 2025 | A | 13,000 | $0.00 | $0 | 23,500 | No | Form 4 |
| Mattessich Antony C. | Jun 17, 2025 | Jun 18, 2025 | A · derivative | 17,000 | $6.18 | $105,060 | 17,000 | No | Form 4 |
| Johnson David Michael | Jun 17, 2025 | Jun 18, 2025 | A | 13,000 | $0.00 | $0 | 179,167 | No | Form 4 |
| Johnson David Michael | Jun 17, 2025 | Jun 18, 2025 | A · derivative | 17,000 | $6.18 | $105,060 | 17,000 | No | Form 4 |
| Srivastava Sapna | Jun 17, 2025 | Jun 18, 2025 | A | 13,000 | $0.00 | $0 | 23,500 | No | Form 4 |
| Srivastava Sapna | Jun 17, 2025 | Jun 18, 2025 | A · derivative | 17,000 | $6.18 | $105,060 | 17,000 | No | Form 4 |
| de los Pinos ElisabetSee Remarks | Jun 2, 2025 | Jun 4, 2025 | M | 10,948 | $5.07 | $55,506 | 493,388 | No | Form 4 |
| de los Pinos ElisabetSee Remarks | Jun 2, 2025 | Jun 4, 2025 | F | 9,948 | $6.16 | $61,280 | 483,440 | No | Form 4 |
| de los Pinos ElisabetSee Remarks | Jun 2, 2025 | Jun 4, 2025 | M · derivative | 10,948 | $5.07 | $55,506 | not reported | No | Form 4 |
| Gibney Anthony SSee Remarks | Jun 2, 2025 | Jun 4, 2025 | A | 150,000 | $0.00 | $0 | 206,933 | No | Form 4 |
| Gibney Anthony SSee Remarks | Jun 2, 2025 | Jun 4, 2025 | A · derivative | 250,000 | $6.16 | $1,540,000 | 250,000 | No | Form 4 |
| Gibney Anthony SSee Remarks | May 16, 2025 | May 20, 2025 | P | 50,000 | $4.90 | Purchase +$245,000 | 58,452 | No | Form 4 |
| Gibney Anthony SSee Remarks | May 16, 2025 | May 20, 2025 | S | 1,519 | $5.15 | Sale −$7,823 | 56,933 | No | Form 4 |
| Gibney Anthony SSee Remarks | May 16, 2025 | May 20, 2025 | P · derivative | 12,500 | $4.90 | Purchase +$61,250 | 12,500 | No | Form 4 |
| Johnson David Michael | May 16, 2025 | May 20, 2025 | P | 20,000 | $4.90 | Purchase +$98,000 | 166,167 | No | Form 4 |
| Johnson David Michael | May 16, 2025 | May 20, 2025 | P · derivative | 5,000 | $4.90 | Purchase +$24,500 | 5,000 | No | Form 4 |
| Kilroy ConorSee Remarks | Apr 16, 2025 | Apr 16, 2025 | S | 7,162 | $5.49 | Sale −$39,319 | 179,313 | No | Form 4 |
| Elazzouzi AmySenior Vice President, Finance | Apr 16, 2025 | Apr 16, 2025 | S | 897 | $5.49 | Sale −$4,925 | 81,381 | No | Form 4 |
| Bitetti Teresa Marie | Mar 31, 2025 | Apr 2, 2025 | A | 21,000 | $0.00 | $0 | 21,000 | No | Form 4 |
| Bitetti Teresa Marie | Mar 31, 2025 | Apr 2, 2025 | A · derivative | 29,000 | $5.86 | $169,940 | 29,000 | No | Form 4 |
| de los Pinos ElisabetSee Remarks | Feb 18, 2025 | Feb 18, 2025 | S | 20,221 | $7.75 | Sale −$156,713 | 482,440 | No | Form 4 |
| Hopkins Janet JillChief Medical Officer | Feb 18, 2025 | Feb 18, 2025 | S | 2,534 | $7.75 | Sale −$19,639 | 269,794 | No | Form 4 |
| Elazzouzi AmySenior Vice President, Finance | Feb 18, 2025 | Feb 18, 2025 | S | 1,404 | $7.75 | Sale −$10,881 | 82,278 | No | Form 4 |
| Plavsic MarkChief Technology Officer | Feb 18, 2025 | Feb 18, 2025 | S | 2,151 | $7.75 | Sale −$16,670 | 209,456 | No | Form 4 |
| Elazzouzi AmySenior Vice President, Finance | Feb 3, 2025 | Feb 4, 2025 | A | 45,240 | $0.00 | $0 | 83,682 | No | Form 4 |
| Elazzouzi AmySenior Vice President, Finance | Feb 3, 2025 | Feb 4, 2025 | A · derivative | 29,760 | $7.68 | $228,557 | 29,760 | No | Form 4 |
| Kilroy ConorSee Remarks | Feb 3, 2025 | Feb 4, 2025 | A | 90,475 | $0.00 | $0 | 186,475 | No | Form 4 |
| Kilroy ConorSee Remarks | Feb 3, 2025 | Feb 4, 2025 | A · derivative | 59,525 | $7.68 | $457,152 | 59,525 | No | Form 4 |
| Hopkins Janet JillChief Medical Officer | Feb 3, 2025 | Feb 4, 2025 | A | 120,635 | $0.00 | $0 | 272,328 | No | Form 4 |
| Hopkins Janet JillChief Medical Officer | Feb 3, 2025 | Feb 4, 2025 | A · derivative | 79,365 | $7.68 | $609,523 | 79,365 | No | Form 4 |
| Plavsic MarkChief Technology Officer | Feb 3, 2025 | Feb 4, 2025 | A | 90,475 | $0.00 | $0 | 211,607 | No | Form 4 |
| Plavsic MarkChief Technology Officer | Feb 3, 2025 | Feb 4, 2025 | A · derivative | 59,525 | $7.68 | $457,152 | 59,525 | No | Form 4 |
| de los Pinos ElisabetSee Remarks | Feb 3, 2025 | Feb 4, 2025 | A | 194,320 | $0.00 | $0 | 502,661 | No | Form 4 |
| de los Pinos ElisabetSee Remarks | Feb 3, 2025 | Feb 4, 2025 | A · derivative | 255,680 | $7.68 | $1,963,622 | 255,680 | No | Form 4 |
| Elazzouzi AmyVice President, Finance | Jan 21, 2025 | Jan 21, 2025 | S | 1,001 | $7.67 | Sale −$7,678 | 38,442 | No | Form 4 |
| de los Pinos ElisabetSee Remarks | Jan 21, 2025 | Jan 21, 2025 | S | 15,955 | $7.67 | Sale −$122,375 | 304,692 | No | Form 4 |
| Hopkins Janet JillChief Medical Officer | Nov 18, 2024 | Nov 18, 2024 | S | 11,822 | $9.36 | Sale −$110,654 | 151,693 | No | Form 4 |
| Elazzouzi AmyVice President, Finance | Oct 29, 2024 | Oct 29, 2024 | S | 553 | $10.74 | Sale −$5,939 | 39,443 | No | Form 4 |
| de los Pinos ElisabetSee Remarks | Oct 29, 2024 | Oct 29, 2024 | S | 9,200 | $10.74 | Sale −$98,808 | 320,647 | No | Form 4 |
| Feder Julie BChief Financial Officer | Oct 18, 2024 | Oct 21, 2024 | M | 17,500 | $2.74 | $47,950 | 151,776 | Yes | Form 4 |
| Feder Julie BChief Financial Officer | Oct 18, 2024 | Oct 21, 2024 | M | 2,631 | $4.25 | $11,182 | 154,407 | Yes | Form 4 |
| Feder Julie BChief Financial Officer | Oct 18, 2024 | Oct 21, 2024 | M | 5,000 | $5.48 | $27,400 | 159,407 | Yes | Form 4 |
| Feder Julie BChief Financial Officer | Oct 18, 2024 | Oct 21, 2024 | S | 25,131 | $12.03 | Sale −$302,326 | 134,276 | Yes | Form 4 |
| Feder Julie BChief Financial Officer | Oct 18, 2024 | Oct 21, 2024 | M · derivative | 17,500 | $2.74 | $47,950 | 68,257 | Yes | Form 4 |
| Feder Julie BChief Financial Officer | Oct 18, 2024 | Oct 21, 2024 | M · derivative | 2,631 | $4.25 | $11,182 | 32,359 | Yes | Form 4 |
| Feder Julie BChief Financial Officer | Oct 18, 2024 | Oct 21, 2024 | M · derivative | 5,000 | $5.48 | $27,400 | 120,547 | Yes | Form 4 |
| de los Pinos ElisabetSee Remarks | Oct 18, 2024 | Oct 18, 2024 | M | 24,992 | $2.74 | $68,478 | 354,839 | Yes | Form 4 |
| de los Pinos ElisabetSee Remarks | Oct 18, 2024 | Oct 18, 2024 | S | 24,992 | $12.04 | Sale −$300,904 | 329,847 | Yes | Form 4 |
| de los Pinos ElisabetSee Remarks | Oct 18, 2024 | Oct 18, 2024 | M · derivative | 24,992 | $2.74 | $68,478 | 336,171 | Yes | Form 4 |
| Plavsic MarkChief Technology Officer | Oct 16, 2024 | Oct 16, 2024 | S | 7,383 | $9.85 | Sale −$72,723 | 121,132 | No | Form 4 |
| de los Pinos ElisabetSee Remarks | Sep 27, 2024 | Oct 1, 2024 | M | 5,474 | $5.76 | $31,530 | 329,847 | No | Form 4 |
| de los Pinos ElisabetSee Remarks | Sep 27, 2024 | Oct 1, 2024 | M · derivative | 5,474 | $5.76 | $31,530 | not reported | No | Form 4 |
| Johnson David Michael | Jun 20, 2024 | Jun 24, 2024 | A | 10,500 | $0.00 | $0 | 146,167 | No | Form 4 |
| Johnson David Michael | Jun 20, 2024 | Jun 24, 2024 | A · derivative | 14,500 | $6.93 | $100,485 | 14,500 | No | Form 4 |
| Srivastava Sapna | Jun 20, 2024 | Jun 24, 2024 | A | 10,500 | $0.00 | $0 | 10,500 | No | Form 4 |
| Srivastava Sapna | Jun 20, 2024 | Jun 24, 2024 | A · derivative | 14,500 | $6.93 | $100,485 | 14,500 | No | Form 4 |
| Mattessich Antony C. | Jun 20, 2024 | Jun 24, 2024 | A | 10,500 | $0.00 | $0 | 10,500 | No | Form 4 |
| Mattessich Antony C. | Jun 20, 2024 | Jun 24, 2024 | A · derivative | 14,500 | $6.93 | $100,485 | 14,500 | No | Form 4 |
| Kilroy ConorGeneral Counsel and Secretary | Apr 2, 2024 | Apr 4, 2024 | A | 96,000 | $0.00 | $0 | 96,000 | No | Form 4 |
| Kilroy ConorGeneral Counsel and Secretary | Apr 2, 2024 | Apr 4, 2024 | A · derivative | 144,000 | $7.40 | $1,065,600 | 144,000 | No | Form 4 |
| de los Pinos ElisabetSee Remarks | Feb 1, 2024 | Feb 2, 2024 | A | 162,935 | $0.00 | $0 | 324,373 | No | Form 4 |
| de los Pinos ElisabetSee Remarks | Feb 1, 2024 | Feb 2, 2024 | A · derivative | 237,065 | $7.77 | $1,841,995 | 237,065 | No | Form 4 |
| Hopkins Janet JillChief Medical Officer | Feb 1, 2024 | Feb 2, 2024 | A | 28,515 | $0.00 | $0 | 163,515 | No | Form 4 |
| Hopkins Janet JillChief Medical Officer | Feb 1, 2024 | Feb 2, 2024 | A · derivative | 41,485 | $7.77 | $322,338 | 41,485 | No | Form 4 |
| Feder Julie BChief Financial Officer | Feb 1, 2024 | Feb 2, 2024 | A | 71,285 | $0.00 | $0 | 134,276 | No | Form 4 |
| Feder Julie BChief Financial Officer | Feb 1, 2024 | Feb 2, 2024 | A · derivative | 103,715 | $7.77 | $805,866 | 103,715 | No | Form 4 |
| Feder Julie BChief Financial Officer | Jan 23, 2024 | Jan 24, 2024 | S | 6,609 | $7.64 | Sale −$50,493 | 62,991 | No | Form 4 |
| de los Pinos ElisabetSee Remarks | Jan 23, 2024 | Jan 24, 2024 | S | 15,853 | $7.64 | Sale −$121,117 | 161,438 | No | Form 4 |
| Matrix Capital Management Company, LP | Nov 9, 2023 | Nov 9, 2023 | P | 1,560,000 | $9.00 | Purchase +$14,040,000 | 6,922,870 | No | Form 4 |
| Johnson David Michael | Nov 8, 2023 | Nov 9, 2023 | P | 9,601 | $7.30 | Purchase +$70,087 | 135,667 | No | Form 4 |
| Johnson David Michael | Nov 8, 2023 | Nov 9, 2023 | P | 10,000 | $7.30 | Purchase +$73,000 | 75,000 | No | Form 4 |
| Johnson David Michael | Nov 8, 2023 | Nov 9, 2023 | P | 10,000 | $7.30 | Purchase +$73,000 | 75,000 | No | Form 4 |
| Johnson David Michael | Nov 7, 2023 | Nov 9, 2023 | P | 76,000 | $7.17 | Purchase +$544,920 | 126,066 | No | Form 4 |
| Johnson David Michael | Nov 7, 2023 | Nov 9, 2023 | P | 47,000 | $7.17 | Purchase +$336,990 | 65,000 | No | Form 4 |
| Johnson David Michael | Nov 7, 2023 | Nov 9, 2023 | P | 47,000 | $7.17 | Purchase +$336,990 | 65,000 | No | Form 4 |
| Feder Julie BChief Financial Officer | Nov 6, 2023 | Nov 7, 2023 | M | 3,900 | $2.74 | $10,686 | 73,500 | Yes | Form 4 |
| Feder Julie BChief Financial Officer | Nov 6, 2023 | Nov 7, 2023 | S | 3,900 | $12.07 | Sale −$47,073 | 69,600 | Yes | Form 4 |
| Feder Julie BChief Financial Officer | Nov 6, 2023 | Nov 7, 2023 | M · derivative | 3,900 | $2.74 | $10,686 | 85,757 | Yes | Form 4 |
| de los Pinos ElisabetSee Remarks | Nov 6, 2023 | Nov 7, 2023 | M | 3,800 | $2.74 | $10,412 | 184,740 | Yes | Form 4 |
| de los Pinos ElisabetSee Remarks | Nov 6, 2023 | Nov 7, 2023 | S | 7,449 | $12.03 | Sale −$89,611 | 177,291 | Yes | Form 4 |
| de los Pinos ElisabetSee Remarks | Nov 6, 2023 | Nov 7, 2023 | M · derivative | 3,800 | $2.74 | $10,412 | 361,163 | Yes | Form 4 |
| Hopkins Janet JillChief Medical Officer | Nov 1, 2023 | Nov 3, 2023 | A | 135,000 | $0.00 | $0 | 135,000 | No | Form 4 |
| Hopkins Janet JillChief Medical Officer | Nov 1, 2023 | Nov 3, 2023 | A · derivative | 200,000 | $8.97 | $1,794,000 | 200,000 | No | Form 4 |
| de los Pinos ElisabetSee Remarks | Oct 30, 2023 | Nov 1, 2023 | S | 9,586 | $6.83 | Sale −$65,472 | 180,940 | No | Form 4 |
| Feder Julie BChief Financial Officer | Oct 30, 2023 | Nov 1, 2023 | S | 3,385 | $6.82 | Sale −$23,086 | 69,600 | No | Form 4 |
| Johnson David Michael | Oct 4, 2023 | Oct 5, 2023 | P | 6,566 | $8.61 | Purchase +$56,533 | 50,066 | No | Form 4 |
| Johnson David Michael | Oct 3, 2023 | Oct 5, 2023 | P | 13,500 | $8.27 | Purchase +$111,645 | 43,500 | No | Form 4 |